FGFR

FGFR(成纤维细胞生长因子受体)是与成纤维细胞生长因子蛋白家族成员结合的受体。其中一些受体与病理状况有关。FGFR3 中的点突变可导致软骨发育不全。在脊椎动物中已鉴定出五种不同的膜 FGFR,它们均属于酪氨酸激酶超家族(FGFR1、FGFR2、FGFR3、FGFR4、FGFR6)。成纤维细胞生长因子家族是发育过程中最重要的旁分泌因子组之一。它们负责决定某些细胞成为中胚层、血管的产生、肢体的生长以及多种细胞类型的生长和分化。

FGFR (Fibroblast growth factor receptors) are the receptors that bind to members of the fibroblast growth factor family of proteins. Some of these receptors are involved in pathological conditions. A point mutation in FGFR3 can lead to achondroplasia. Five distinct membrane FGFR have been identified in vertebrates and all of them belong to the tyrosine kinase superfamily (FGFR1, FGFR2, FGFR3, FGFR4, FGFR6). The fibroblast growth factor family constitutes one of the most important groups of paracrine factors that act during development. They are responsible for determining certain cells to become mesoderm, for the production of blood vessels, for limb outgrowth, and for the growth and differentiation of numerous cell types.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
PD 174265

PD 174265 是一种高选择性、可逆性的 EGFR/ErbB2 酪氨酸激酶抑制剂 (IC50=0.45 nM) 和细胞分化诱导剂,通过阻断受体自磷酸化及下游 ERK 信号通路 (对全长 ERK IC50=0.45 μM) 有效抑制肿瘤生长,并在体内模型中展现抗肿瘤活性且无明显毒性,同时促使少突胶质前体细胞从增殖状态转化为分化状态,显著上调 CNP、PLP 和 MBP 等髓鞘蛋白的表达并诱导突起分支,且对胰岛素、PDGF 及碱性 FGF 受体等其他激酶无抑制作用,是研究人表皮样癌及多发性硬化症中髓鞘修复机制的重要工具分子。

216163-53-0
Control
98.35%
PD 174265

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础